AGL 38.50 Decreased By ▼ -1.08 (-2.73%)
AIRLINK 129.00 Decreased By ▼ -2.22 (-1.69%)
BOP 6.90 Increased By ▲ 0.09 (1.32%)
CNERGY 4.48 Decreased By ▼ -0.23 (-4.88%)
DCL 8.30 Decreased By ▼ -0.14 (-1.66%)
DFML 40.25 Decreased By ▼ -1.22 (-2.94%)
DGKC 79.75 Decreased By ▼ -2.34 (-2.85%)
FCCL 32.30 Decreased By ▼ -0.80 (-2.42%)
FFBL 70.25 Decreased By ▼ -2.62 (-3.6%)
FFL 11.85 Decreased By ▼ -0.41 (-3.34%)
HUBC 108.00 Decreased By ▼ -2.74 (-2.47%)
HUMNL 13.75 Decreased By ▼ -0.76 (-5.24%)
KEL 4.96 Decreased By ▼ -0.23 (-4.43%)
KOSM 7.50 Decreased By ▼ -0.11 (-1.45%)
MLCF 37.75 Decreased By ▼ -1.15 (-2.96%)
NBP 68.25 Increased By ▲ 4.24 (6.62%)
OGDC 186.50 Decreased By ▼ -6.32 (-3.28%)
PAEL 24.81 Decreased By ▼ -0.87 (-3.39%)
PIBTL 7.33 Decreased By ▼ -0.01 (-0.14%)
PPL 147.56 Decreased By ▼ -6.51 (-4.23%)
PRL 24.99 Decreased By ▼ -0.84 (-3.25%)
PTC 16.81 Decreased By ▼ -1.00 (-5.61%)
SEARL 78.80 Decreased By ▼ -3.50 (-4.25%)
TELE 7.49 Decreased By ▼ -0.27 (-3.48%)
TOMCL 32.50 Decreased By ▼ -0.96 (-2.87%)
TPLP 8.17 Decreased By ▼ -0.32 (-3.77%)
TREET 16.65 Increased By ▲ 0.03 (0.18%)
TRG 56.00 Decreased By ▼ -1.40 (-2.44%)
UNITY 27.70 Increased By ▲ 0.19 (0.69%)
WTL 1.32 Decreased By ▼ -0.05 (-3.65%)
BR100 10,361 Decreased By -143.2 (-1.36%)
BR30 30,470 Decreased By -756.2 (-2.42%)
KSE100 96,844 Decreased By -1235.4 (-1.26%)
KSE30 30,197 Decreased By -361.9 (-1.18%)

The World Health Organisation (WHO) and an international initiative launched a programme to provide anti-tuberculosis drugs to people in poor countries who are unable to cover their full medical needs.
The $26.8 million programme will deliver drugs to around 750,000 people in 19 countries, covering their anti-tuberculosis drug needs for the rest of this year and 2008, the Stop TB Partnership, hosted by the WHO, and the UNITAID initiative said in a joint statement.
The initiative will provide drugs to countries expanding their TB control efforts and that have been promised support from the Global Fund to Fight AIDS, Tuberculosis and Malaria or another donor, but do not yet have the funds. A six-month course of treatment for TB for someone of average weight costs $20.
TB and AIDS are the main health threats in Africa and are closely linked, with victims of one often vulnerable to the other. Worldwide, 8.8 million new cases of TB and 1.6 million deaths from it occur each year. If left untreated, TB can develop into drug-resistant strains.
"This is the first line to prevent the creation of drug resistance," Marcos Espinal, executive secretary of the Stop TB Partnership, told a news conference.
The project is restricted to anti-TB treatments suitable for people whose TB is not resistant to standard therapies. It will also allow the creation of a stockpile of anti-TB drugs. The drugs are sourced from four generics manufacturers in India, said Robert Matiru, operations manager of the Stop TB Partnership's Global Drugs Facility.
They are Lupin, Cadila, Sandoz India and Svizera Europe, he said. The project will provide first-line TB drugs to Bangladesh, Bosnia, Burkina Faso, Cameroon, Cote d'Ivoire, Guinea, Iraq, Kenya, Madagascar, Mali, Mozambique, Myanmar, Niger, Nigeria, Rwanda, Tajikistan, Gambia, Togo and Uganda.

Copyright Reuters, 2007

Comments

Comments are closed.